Epithalon
Telomerase Activator
Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal gland epithalamin complex. Studied for telomerase activation, telomere elongation, circadian rhythm restoration via melatonin synthesis, and broad anti-aging genomic effects.
Format
10mg / vial
Purity
>99.1%
Category
Longevity
Storage
2–8 °C
Research Price
€99
10mg / vial
RESEARCH USE ONLY
This compound is sold exclusively for in-vitro laboratory research. It is not intended for human consumption, therapeutic use, or self-administration. You must be 18+ and a qualified researcher to purchase.
Complete Your Research with the Pen Kit
Precise, painless, repeatable. The clinical-grade injection pen with 32G ultra-fine needles, bacteriostatic water, and your choice of peptide — ready to use out of the box.
€189
View details →Research Protocol Bundles
Longevity Protocol
Epithalon + MOTS-C + NAD+
Three compounds at the frontier of cellular longevity research — Epithalon for telomere maintenance, MOTS-C for mitochondrial signalling, and NAD+ precursor for metabolic cofactor support.
Bundle total
€277
12% bundle saving
Documented Research Parameters
Research Dose
5–10 mg per cycle
Frequency
Once daily for 10–20 consecutive days (cycle)
Duration
1–2 cycles per year (research observation)
Half-Life
<1 hour
Route(s)
Subcutaneous · Intramuscular · Intranasal (research formulations)
Solubility
Water
Reconstitution
2 ml bacteriostatic water per 10 mg vial
Key Research Findings
Stimulates telomerase activity in human somatic cells — key to telomere elongation research.
Regulates melatonin synthesis via pineal gland, supporting circadian rhythm restoration in models of age-related decline.
Demonstrated anti-tumor activity in research by restoring normal cell cycle regulation.
Cyclical administration (10-day courses) reflects the protocol used in Khavinson's seminal aging research.
Administration Reference
Subcutaneous injection in the abdominal region is the most documented route. Daily administration for 10–20 consecutive days constitutes a research cycle, as used in the original Khavinson literature. Sites are rotated across the abdomen, outer thighs, and upper arms. Intranasal formulations have been explored for CNS delivery research but require specialist preparation.
Documented Combination Protocols
IMPORTANT RESEARCH DISCLAIMER
This compound is for in-vitro research and laboratory use only. It has not been evaluated or approved by any regulatory authority for human therapeutic use. It must not be used as a food, drug, or cosmetic. SYNTHEXA assumes no liability for misuse. Handle in accordance with Good Laboratory Practice.